GeneticsbioRxivPreprint
Base editing of β0 thalassemia mutations as a therapeutic strategy for β-hemoglobinopathies: efficacy and genotoxicity studies
Giulia Hardouin, Pierre Martinucci, Samantha Scaramuzza…·Annarita Miccio
Preclinical safety and efficacy studies of a new gene therapy approach for patients with severe β-hemoglobinopathies.
DOI 10.1101/2025.08.21.671453